The global amyotrophic lateral sclerosis market is on an upward trajectory, demonstrating significant potential for growth and innovation. According to the latest insights from Future Market Insights ...

Abnormal kinase signaling can promote other harmful traits, such as neuroinflammation and neuronal cell death. On the other ...

An amyotrophic lateral sclerosis (ALS) diagnosis is often viewed as getting a death sentence. After diagnosis, people with ...

Amyotrophic lateral sclerosis (ALS) is a disease that destroys the nerves necessary for movement. About 30,000 people in the ...

Lisa Hughart was a regular at sporting events for the last 30 years, supporting her children, then grandchildren. Dozens of people came to honor her and raise money to fight the deadly disease ...

Ferrer’s R&D work focuses on neurological and pulmonary diseases, and the Spanish pharma has bought into ALS assets in the ...

The viral Ice Bucket Challenge originated in 2014 benefiting the ALS Foundation. Now, it's been rebranded to support mental ...

Advocates for patients with amyotrophic lateral sclerosis — a fatal condition known as Lou Gehrig’s disease — urged lawmakers ...

Boston College baseball lost the third game of its series against Miami at Fenway Park on Sunday in the annual ALS Awareness ...

A man with ALS received a Neuralink BCI implant, allowing him to control a laptop cursor and generate his own voice using AI.

The Eagle-Tribune interviewed Charles “Chuck” Johnson and Nicole Johnson on April 11 for a story to show how the North ...

Prilenia Therapeutics has entered into a collaboration & license agreement with Ferrer for the commercialization and further development of pridopidine in Europe and other select markets.